Inferensys

Guide

How to Build a Knowledge Graph for Drug Target Relationships

A practical, code-rich tutorial for constructing a queryable biomedical knowledge graph that maps genes, proteins, diseases, and compounds to uncover novel therapeutic relationships.
Knowledge engineer constructing knowledge base on laptop, document hierarchy visible, casual office setup.

This guide explains how to construct a biomedical knowledge graph, a foundational tool for AI-driven drug discovery that maps complex relationships between biological entities.

A biomedical knowledge graph is a structured network representing entities—genes, proteins, diseases, compounds—and their relationships. Unlike a traditional database, its graph structure excels at uncovering hidden connections, such as novel drug target associations. You build it by extracting data from public sources like UniProt and DrugBank, resolving entities to avoid duplicates, and storing the network in a graph database such as Neo4j or Amazon Neptune. This creates a queryable foundation for biological discovery.

The core value lies in applying graph algorithms and Graph Neural Networks (GNNs) for predictive tasks like link prediction. For example, you can train a GNN to infer missing relationships between a protein and a disease, generating new, testable hypotheses. This guide provides the practical steps to move from raw data to an intelligent system, a key component in our pillar on Bio-AI and AI-Guided Drug Target Identification.

FOUNDATIONAL TOOLS

Key Concepts: Biomedical Knowledge Graphs

Building a knowledge graph for drug discovery requires integrating specialized tools and data sources. These cards cover the essential components for mapping complex biological relationships.

06

Entity Resolution with RecordLinkage

Entity resolution is the critical step of merging records that refer to the same real-world entity (e.g., a gene) from different data sources. The Python recordlinkage toolkit automates this.

  • Performs fuzzy matching on entity names and identifiers to resolve discrepancies.
  • Uses blocking techniques to compare millions of records efficiently.
  • Accurate resolution prevents duplicate nodes and ensures your graph's relationships are correct. For a deeper dive into the architecture of such systems, see our guide on How to Architect an AI-Driven Target Identification Platform.
FOUNDATION

Step 1: Design Your Graph Schema

The schema is the blueprint for your biomedical knowledge graph, defining the types of entities and relationships you will model. A well-designed schema ensures your data is queryable and supports accurate AI predictions.

Begin by defining your core entity types (nodes) and relationship types (edges). For drug target discovery, essential nodes include Gene, Protein, Disease, Compound, and BiologicalProcess. Key relationships capture known interactions like Gene_ENCODES_Protein, Protein_INTERACTS_WITH_Protein, and Compound_TARGETS_Protein. This explicit mapping of your domain's ontology is the first step in building a usable knowledge graph.

Next, assign properties to each entity and relationship. A Protein node should have properties like uniprot_id, sequence, and function. A TARGETS relationship might include affinity and evidence_source. Use tools like Neo4j's Cypher language or a visual schema designer. This structured foundation is critical for effective data ingestion and for training downstream graph neural networks (GNNs) for link prediction.

KNOWLEDGE GRAPH DATABASES

Tool Comparison: Neo4j vs. Amazon Neptune

A direct comparison of two leading graph databases for building a biomedical knowledge graph to map drug target relationships.

Feature / MetricNeo4jAmazon Neptune

Graph Model

Property Graph (Cypher)

Property Graph & RDF (SPARQL, Gremlin)

Deployment Model

Self-managed or AuraDB Cloud

Fully-managed AWS service

Query Language

Cypher (native)

Gremlin, SPARQL, openCypher

ACID Compliance

Integrates with Python/R

Native GNN Support

Graph Data Science library

Via Amazon SageMaker

Typical Latency for 3-hop Path Query

< 100 ms

< 200 ms

Cost Model for 100GB Graph

$500-1,500/month (AuraDB)

$800-2,000/month (on-demand)

PRACTICAL APPLICATIONS

Use Cases and Query Examples

A biomedical knowledge graph unlocks powerful queries for drug discovery. These examples show how to find novel targets, understand disease mechanisms, and predict drug repurposing opportunities.

02

Predict Drug Repurposing Candidates

Discover existing drugs that could treat new conditions by analyzing shared target profiles and side effect similarity. This accelerates development by leveraging known safety data.

  • Method: Perform a graph similarity search between the disease's target network and the known target networks of approved drugs.
  • Key Data Sources: DrugBank for drug-target relationships, SIDER for side effects.
  • Actionable Output: A shortlist of drugs with computational evidence for off-label use, prioritized for clinical trial analysis.
03

Understand Mechanism of Action

Deconstruct how a drug works by mapping its multi-hop effects through the biological network. This is critical for explaining efficacy and anticipating resistance.

  • Graph Technique: Use a Graph Neural Network (GNN) for link prediction to infer missing relationships between a drug's primary target and downstream phenotypic nodes.
  • Visualization: Render the subgraph connecting drug → protein → pathway → biological process → disease.
  • Value: Provides a systems-biology view for regulatory submissions and guides combination therapy design.
05

Identify Biomarkers for Patient Stratification

Find genomic or proteomic signatures that predict treatment response by connecting genetic variants to drug response data via intermediate molecular phenotypes.

  • Graph Traversal: Start from a drug node, traverse to its target, then to associated genetic variants (from GWAS Catalog), and finally to clinical outcome nodes.
  • Use Case: In oncology, identify mutations that make a tumor cell dependent on a specific pathway, indicating which patient subgroup will benefit from a pathway inhibitor.
  • Output: A set of candidate biomarkers to validate in real-world evidence datasets.
06

Map Competitive Landscape for a Target

Analyze the competitive intensity around a target by querying all drugs in development, their development stages, and assigning companies. This informs portfolio strategy.

  • Data Integration: Ingest clinical trial data (ClinicalTrials.gov) and patent information, linking them to target and company entities.
  • Strategic Query: "Show all Phase II/III drugs targeting protein P, their mechanisms, and the organizations developing them."
  • Deliverable: A dynamic competitive intelligence report generated directly from the knowledge graph, highlighting white space opportunities.
TROUBLESHOOTING

Common Mistakes

Building a biomedical knowledge graph is a powerful but intricate process. These are the most frequent technical pitfalls developers encounter and how to fix them.

Duplicate nodes for the same biological entity (e.g., 'TP53', 'P53', 'cellular tumor antigen p53') destroy graph integrity. This happens due to inconsistent data normalization and a lack of a canonical identifier mapping.

How to fix it:

  • Implement a pre-processing pipeline that maps all incoming data to standard identifiers (e.g., UniProt IDs for proteins, ENSEMBL IDs for genes, MONDO IDs for diseases) before ingestion.
  • Use dedicated tools like Biomedical Concept Identifier (BCI) services or public mapping files from NCBI.
  • Create a synonym management table in your ETL process to collapse variations into a single canonical node ID.
  • For advanced cases, apply fuzzy matching algorithms on entity names, but always resolve to the standard ID.
Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.